D-0293-2026 Class II Ongoing

Recalled by Graviti Pharmaceuticals Private Limited — Hyderabad

FDA drug recall D-0293-2026 was initiated by Graviti Pharmaceuticals Private Limited on Jan 10, 2026 and is designated Class II. Reason for recall: Presence of Foreign Substance The recall status is ongoing. Affected quantity: 4212 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 28, 2026
Initiation Date
Jan 10, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4212 bottles

Product description

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.

Reason for recall

Presence of Foreign Substance

Distribution pattern

U.S. Nationwide

Code information

Lot# FUB125042G; Exp. 05/13/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0293-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0293-2026. Report a data issue: hello@regdatalab.com.